Study subgroups

Frequency of adverse events (%)

P value

Male (n = 124) Vs. female (n = 24)

36 (25.7%) Vs. 07 (29.2%)

0.72^ns

Age ≥ 50 years (n = 96) Vs. < 50 years (n = 68 )

30 (31.2%) Vs. 13 (19.1%)

0.24^ns

BMI ≥ 25 (n = 103) Vs. < 25 (n = 61)

25 (24.2%) Vs. 18 (29.5%)

0.82^ns

Chest pain ≥ 360 M(n = 34) Vs. < 360 M (n = 130)

09 (26.4%) Vs. 34 (26.1%)

0.88^ns

Smoker (n = 76) Vs. non-smoker (n = 88)

18 (23.7%) Vs.25 (28.4%)

0.49^ns

Diabetic (n = 46) Vs. non-diabetic (n = 118)

26 (56.5%) Vs. 17 (14.4%)

0.000^s

Hypertensive (n = 101) Vs. normotensive (n = 63)

37 (36.6%) Vs. 06 (09.5%)

0.000^s

Dyslipidemia (n = 131) Vs. no dyslipidemia (n = 33)

18 (54.5%) Vs. 25 (19.1%)

0.000^s

F/H/O CAD present (n = 46) Vs. absent (n = 118)

17 (27.0%) Vs. 26 (22.0%)

0.73^ns

Anterior MI (n = 116) Vs. Inferior MI (n = 48)

29 (25.0%) Vs. 14 (29.1%)

0.66^ns